ViewPoint Therapeutics Receives $4,000,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
    ViewPoint Therapeutics
  • Mailing Address
    953 Indiana St. San Francisco, CA 94107 USA
  • Company Description
    ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    With this financing, we plan to build on our promising preclinical results and prepare for initial human clinical studies in patients with cataracts that are poorly addressed with conventional surgery.
  • M&A Terms
  • Venture Investor
    Mission Bay Capital
  • Venture Investor
    Lagunita Capital
  • Venture Investor
    BioVentures Investors
  • Venture Investor
  • Venture Investor
    Asset Management Ventures

Trending on Xconomy